- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.05. | Axe falls on Stealth Bio staff after FDA rejects lead drug | ||
| 30.05. | GRIN raises $140m for epilepsy drug, and other financings | ||
| 29.05. | MSD and Daiichi Sankyo pull HER3-DXd's FDA filing | ||
| 29.05. | Old COVID tweet lands Pfizer in new trouble with PMCPA | ||
| 29.05. | Moderna's $760m-plus flu vaccine contracts are nixed by HHS | ||
| 29.05. | Data sets up filing of new GSK antibiotic this year | ||
| 29.05. | Eisai says patent win blocks Lenvima generic to 2036 | ||
| 28.05. | InflaRx stock halves after it drops lead drug | ||
| 28.05. | FDA fast-tracks Teva's coeliac disease treatment | ||
| 28.05. | Manufacturing issues scupper Savara's lead drug filing | ||
| 28.05. | Lilly takes on Vertex in non-opioid pain with SiteOne buy | ||
| 28.05. | CDC stops backing COVID jabs for pregnant women, children | ||
| 27.05. | UK cancer centre launches AI-powered detection drive | ||
| 27.05. | ASCO 25: Merus bispecific scores again in HNSCC | ||
| 27.05. | Sanofi admits giving free Olympics tickets to patients | ||
| 27.05. | Autolus closes on EU okay for leukaemia cell therapy | ||
| 27.05. | Roche takes new antibiotic into phase 3 for 'urgent threat' | ||
| 26.05. | ASCO 25: Can GLP-1 drugs reduce cancer risk? | ||
| 26.05. | ASCO 25: Jazz, PharmaMar reveal SCLC survival data | ||
| 23.05. | ASCO 25: Roche places Itovebi marker in breast cancer | ||
| 23.05. | RFK Jr spreading 'harmful myths' on Alzheimer's research | ||
| 23.05. | NICE relents and backs drug for IgAN from CSL Vifor | ||
| 23.05. | GSK claims first approval for Nucala in COPD | ||
| 23.05. | Digital player Hinge Health rises sharply after NYSE debut | ||
| 22.05. | AZ partners with Aptar on kidney disease-detecting AI |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .